1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. https://doi.org/10.1182/blood-2016-03-643544 . Epub 2016 Apr 11. Review.
2. Hasserdjian RP, Orazi A, Brunning RD, Germing U, Le Beau MM, Porwit A, Baumann I, Hellström-Lindberg E, List AF, Cazzola M, Foucar K. Myelodysplstic syndromes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 98–106.
3. Zini G. Diagnostics and prognostication of myelodysplastic syndromes. Ann Lab Med. 2017;37(6):465–74. https://doi.org/10.3343/alm.2017.37.6.465 . Review.
4. Weinberg OK, Hasserdjian RP. The current approach to the diagnosis of myelodysplastic syndromes. Semin Hematol. 2019;56(1):15–21.
5. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A, Thiele J, Foucar K, Döhner H, Bloomfield CD. Acute leukemia with recurrent cytogenetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 130–49.